# Expansion of SCG/GCG-Based CAD Sceering: Inclusion of Healthy Controls and CCTA Patients

Study · id `cardio:ct-nct06880133` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06880133](<https://clinicaltrials.gov/study/NCT06880133>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06880133

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1600 participants.

## Technical summary

Registry record NCT06880133. Allocation not applicable; no masking; primary purpose screening. Start 2021-11-12 (actual); primary completion 2023-12-26 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 1600 participants (enrolled count; ClinicalTrials.gov record NCT06880133, source copy `cardio:ctgov-nct06880133-2025-03-17`, retrieved 2026-10-26)
- Started: 2021-11-12 (actual) (ClinicalTrials.gov record NCT06880133, source copy `cardio:ctgov-nct06880133-2025-03-17`, retrieved 2026-10-26)
- Primary completion: 2023-12-26 (actual) (ClinicalTrials.gov record NCT06880133, source copy `cardio:ctgov-nct06880133-2025-03-17`, retrieved 2026-10-26)
- Completion: 2025-02-01 (actual) (ClinicalTrials.gov record NCT06880133, source copy `cardio:ctgov-nct06880133-2025-03-17`, retrieved 2026-10-26)
- Countries: Uzbekistan (ClinicalTrials.gov record NCT06880133, source copy `cardio:ctgov-nct06880133-2025-03-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06880133-2025-03-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Expansion of SCG/GCG-Based CAD Sceering: Inclusion of Healthy Controls and CCTA Patients
- Acronym: HF-CAD-CCTA
- Condition: Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
- Intervention (Device): Seismocardiography (SCG) and Gyrocardiography (GCG) Screening
- Lead sponsor: Heart Force Medical Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)

## Provenance

Content hash: fc2053a166b92e4ca4d0754351a31230fcbd908114230c5dc3a6edd530ac6452
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
